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Summary
The RPGR (retinitis pigmentosa GTPase regulator) gene
for RP3, the most frequent genetic subtype of X-linked
retinitis pigmentosa (XLRP), has been shown to be mu-
tated in 10%–15% of European XLRP patients. We
have examined the RPGR gene for mutations in a cohort
of 80 affected males from apparently unrelated XLRP
families, by direct sequencing of the PCR-amplified
products from the genomic DNA. Fifteen different pu-
tative disease-causing mutations were identified in 17 of
the 80 families; these include four nonsense mutations,
one missense mutation, six microdeletions, and four in-
tronic-sequence substitutions resulting in splice defects.
Most of the mutations were detected in the conserved
N-terminal region of the RPGR protein, containing tan-
dem repeats homologous to those present in the RCC-
1 protein (a guanine nucleotide-exchange factor for Ran-
GTPase). Our results indicate that mutations either in
as yet uncharacterized sequences of the RPGR gene or
in another gene located in its vicinity may be a more
frequent cause of XLRP. The reported studies will be
beneficial in establishing genotype-phenotype correla-
tions and should lead to further investigations seeking
to understand the mechanism of disease pathogenesis.
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Introduction
X-linked retinitis pigmentosa (XLRP) is a severe form
of retinal degeneration with an early onset of night blind-
ness and progressive reduction of the visual field (Bird
1975; Fishman et al. 1988). Two major XLRP loci have
been mapped: RP2 (to Xp11.3-p11.23) and RP3 (at
Xp21.1) (for a review, see Aldred et al. 1994; Fujita and
Swaroop 1996). The proportion of these loci varies in
different populations; however, RP3 seems to be more
frequent, accounting for 60%–90% of affected pedi-
grees (Musarella et al. 1990; Ott et al. 1990; Teague et
al. 1994; Fujita et al. 1997). Complete sequencing of the
genomic region spanning the deletions in two XLRP pa-
tients led to the cloning of the RPGR (retinitis pigmen-
tosa GTPase regulator) gene, which was shown to be
mutated in 10%–15% of European XLRP families
(Meindl et al. 1996; Roepman et al. 1996). The RPGR
gene encodes a putative protein of 815 amino acids, with
six tandem-repeat units in the amino-terminal region
that have high homology to the repeats present in the
RCC-1 protein (Ohtsubo et al. 1987), a guanine nucle-
otide-exchange factor (GEF) for Ran-GTPase (Drivas et
al. 1990).
The goal of the present study was to elucidate the
spectrum of RPGR mutations responsible for XLRP.
Here we report a comprehensive analysis of the RPGR
gene in 80 patients from independent XLRP families.
Subjects and Methods
Details of research procedures are similar to those re-
cently described elsewhere (Fujita et al. 1997), and hu-
man subjects’ participation was in accordance with in-
stitutional guidelines and the Declaration of Helsinki.
The sequences of RPGR primers used for reverse-tran-
scriptase–PCR (RT-PCR) analysis in this study are as
follows: F5 (exon 3, sense), 5′-GAT TAG GAT CAA
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Table 1
RPGR Mutations in Patients with XLRP
Mutationa,b Patient(s) Exon(s)/IVSb Nucleotide Changea Effect of Mutation
Meiosis/Meio-
ses Examined
Nonsense:
G52X A520 Exon 2 GrT at 213 Glyrstop 4
W164X A101 Exon 6 GrA at 551 Trprstop 4
Q236X A224 Exon 7 CrT at 765 Glnrstop 1
E374X A863 Exon 10 GrT at 1179 Glurstop 3
Missense:
G60V A507, A910 Exon 3 GrT at 238 GlyrVal 4, 1
Deletion:
430delC A434 Exon 5 C at 430 Frameshift 1
928delA A109, A463 Exon 8 A at 928 Frameshift 2, 1
Deletion of
exons 8–10
A380 Exons 8-10 Exons 8–10 Splice defect and
frameshift
2
del1320/1338 A567 Exon 11 19 bp at 1320–1338 Frameshift 5
del1571/1572 A924 Exon 13 CA at 1571–1572 Frameshift 7
del1641/1644 A662 Exon 14 ACAA at 1641–1644 Frameshift 2
Splicing:
IVS43 A779 IVS4 donor site ArG at 3693 Exon 4 skipping,
in-frame deletion
1
IVS75 A387 IVS7 donor site GrA at 8375 Exon 7 skipping,
in-frame deletion
1
a Numbered according to Meindl et al. (1996).
b IVS  intervening sequence (intron).
AGT CAG CCA TC-3′; F2 (exon 5, sense), 5′-GGTGGA
AAT AAT GAA GGA CAG TTG G-3′; B3 (exon 6, an-
tisense), 5′-GGT CAC TTG CTG AGG GAC ACA G-
3′; and B8 (exon 9, antisense), 5′-CGT GGC GAC CAT
CTC CAA AAG-3′.
Results
We have examined the RPGR gene for mutations in
genomic DNA derived from 80 affected males from a
cohort of apparently unrelated XLRP families (68North
American and 12 Swedish). The genomic DNAwas used
to amplify exons 2–19 of theRPGR gene (corresponding
to 198% of the coding region) and their flanking intronic
sequences (for primers used, see Meindl et al. 1996; for
methods, see Fujita et al. 1997). The primer set for the
reported exon 1 (Meindl et al. 1996) was not used, be-
cause of inconsistent results of PCR amplification. PCR
products were directly sequenced, and the sequence was
compared with the normal RPGR gene. Fifteen different
putative disease-causing mutations were identified in 17
of the 80 families; these include four nonsense muta-
tions, one missense mutation, six microdeletions, and
four intronic-sequence substitutions resulting in splice
defects. All 17 mutations cosegregated with the disease
in appropriate family members that were available for
the study. Mutations reported here are designated ac-
cording to the Ad Hoc Committee on Mutation No-
menclature (1996).
Nonsense Mutations
Single-base substitutions that result in premature ter-
mination codons were identified in four XLRP patients
(table 1). All of these mutations are expected to produce
a truncated and probably nonfunctional RPGR protein.
Missense Mutation
A change of Gly codon 60 (GGC) to a Val codon
(GTC) was detected in two apparently unrelated patients
(see table 1) but not in 100 normal and 78 other XLRP
chromosomes. The Gly60 residue is conserved in the
mouse Rpgr protein (D. Yan and A. Swaroop, unpub-
lished data) and in RCC1 proteins from different species
(Meindl et al. 1996). This suggests that G60V is a caus-
ative mutation. The G60V mutation has also been re-
ported in another group of XLRP families (Bruns et al.
1997).
Two additional exonic variations were identified in
one XLRP patient each: (i) ArG at nucleotide 282 in
exon 3 and (ii) CrG at nucleotide 844 in exon 8. The
ArG change is not detected in 71 normal and 79 other
examined XLRP chromosomes, whereas the CrG
change is not present in 79 other examined XLRP chro-
mosomes. Since both changes result in conservative
amino acid substitutions (I75V and A262G), these are
probably not causative mutations.
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Figure 1 A,Genomic sequence showing a 19-bp deletion in exon
11 of the RPGR gene in patient A567 (family XLRP-236). For com-
parison, the uninterrupted sequence in an unaffected individual is also
shown. B, PCR-amplified products of RPGR exon 11, showing seg-
regation of the 19-bp deletion in the XLRP-236 family. A smaller
product is observed in two affected brothers (blackened squares) and
their heterozygous mother (circle with a black dot), whereas the un-
affected male sibling (unblackened square) shows the product of cor-
rect size.
Deletion Mutations
In seven XLRP patients, six different intragenic de-
letions were identified within the coding sequence of the
RPGR gene (see table 1). A typical representation of our
mutation analysis is provided in figure 1, which shows
a 19-bp deletion of nucleotides 1320–1338 in exon 11
of one family. This deletion would result in a frameshift
and premature stop codon. In another family, exons
8–10 could not be amplified from the genomic DNA of
the proband (A380). Sequencing of the total RT-PCR
products obtained from lymphocyte RNA of this pro-
band confirmed the deletion of exons 8–l0 and revealed
an aberrant splicing of the RPGR transcript, apparently
induced by the deletion (data not shown).
Splice-Site Mutations
Mutations at the splice sites were identified in four
patients. Two of the nucleotide substitutions were ob-
served at the 5′ splice-donor sites (IVS43 and IVS75;
see table 1) and cosegregated with the disease in the
respective families. Sequencing of the total RT-PCR
products spanning the respective exonic regions showed
that both sequence changes resulted in exon skipping
and, consequently, in in-frame deletion of an RCC1-
homology repeat (data not shown). IVS43 and
IVS75 are, therefore, expected to be causative muta-
tions. Two other splice-site mutations (IVS103 and
IVS13-8)—and their effect on the RPGR gene prod-
uct—have been described elsewhere (Fujita et al. 1997).
Polymorphisms and Sequence Variations
Several polymorphisms (summarized in table 2) were
observed during the mutation search. These sequence
variations were detected in both affected and unaffected
individuals and accounted for 12% of the examined
population. The two sequence variations in exon 11
have been reported previously, by Roepman et al.
(1996), in unaffected individuals and produce conser-
vative amino acid substitutions. In our study, these two
changes cosegregated in the population and were de-
tected in seven patients. In addition, three intronic
changes were identified in the variant sequence regions
farther from the splice sites: (i) a GrA substitution in
the intron 1 splice-acceptor region, IVS1-15 (detected in
nine patients); (ii) an ArG substitution in the intron 10
splice-donor region, IVS1016 (detected in five pa-
tients); and (iii) insertion of one nucleotide (A) in the
intron 15 splice-donor region, after IVS1517 (in one
patient). The possible effect of these changes on splicing
has not been determined.
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Table 2
RPGR Sequence Variations Detected in XLRP Patients
Nucleotide Changea Location
Effect on Coding
Sequence
G or A at 1223 Exon 10 Silent (codon 388
Ala)
G or A at 1333 Exon 11 Conservative substi-
tution (codon 425;
ArgrLys)
A or G at 1350 Exon 11 Conservative substi-
tution (codon 431;
IlerVal)
G or A at 1756 Exon 14 Substitution (codon
566 GlyrGlu)
G or A at 8715 IVS1-15 Not determined
T or C at 156668 IVS12-68 Not determined
T or C at 156697 IVS12-97 Not determined
A or G at 163111 IVS1311 Not determined
T or C at 230011 IVS1811 Not determined
a The first nucleotide shown is more common in the population
tested.
Figure 2 Schematic diagram of the RPGR cDNA, showing distribution of mutations identified in this report and others (Meindl et al.
1996; Roepman et al. 1996). Putative functional domains in the RPGR protein are indicated. The number of observed mutations/total number
of families studied is given in parentheses, next to the reference.
Discussion
A majority of RPGR mutations were found to be
unique to a single family, although one missense mu-
tation and one single-base-pair deletion were detected in
presumably unrelated patients (see table 1). One of the
nonsense mutations (G52X) has been described else-
where (Meindl et al. 1996), and the G60V missense mu-
tation has also been reported (Bruns et al. 1997). De-
tection of a large number of independent mutations
(even in a mostly North American population) suggests
a high new-mutation rate of the RPGR gene and little
or no founder effect. Preliminary linkage-disequilibrium
studies with several polymorphic markers in the RP3
region also showed distinct haplotypes in most of the
studied patients, providing evidence against a common
origin of most XLRP mutations (R. Fujita and A. Swa-
roop, unpublished data).
The locations of the 15 different mutations identified
in this study and of the 12 mutations reported elsewhere
(Meindl et al. 1996; Roepman et al. 1996) are shown
in figure 2. Most of the mutations were detected in the
conserved N-terminal region of the RPGR protein, con-
taining tandem repeats homologous to those present in
the RCC-1 protein. Our analysis validates both the sug-
gested functional importance of this region and a pos-
sible GEF function of the RPGR gene product. It should
also be noted that the three in-frame deletions caused
by splice defects remove one of the six RCC1-homology
repeats from the resulting RPGR protein (for repeat
units, see Meindl et al. 1996). Apparently, the loss of
even one repeat may lead to XLRP. So far, no mutation
has been identified in exons 16–19. Mutations in the C-
terminal region encoded by these exons may not have a
significant effect on protein function or may lead to dis-
eases other than retinitis pigmentosa. The nature and
location of RPGR mutations (in-frame deletions and
missense mutations, in particular) should provide in-
sights into the function of the RPGR protein by iden-
tifying critical domains/residues that, when altered, cre-
ate functionally defective molecules.
In agreement with previous studies (Meindl et al.
1996; Roepman et al. 1996), we were able to demon-
strate RPGR mutations in only 20% of the examined
XLRP patients. One possible explanation for this low
frequency can be the heterogeneity of disease genotype
in the studied population. However, in 11 families in
which the mutation could be localized to the RP3 region,
only two causative mutations were detected (Fujita et al.
1997), and the RP3 subtype consistently accounts for
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60%–90% of genotyped XLRP pedigrees (Musarella et
al. 1990; Ott et al. 1990; Teague et al. 1994; Fujita et
al. 1997). It is possible that the RPGR gene contains as
yet unidentified hotspots in sequences that have not been
screened, such as the promoter region or intronic se-
quences and exon 1. Novel uncharacterized exons and/
or inversions of large genomic regions (spanning com-
plete exons) may also account for some of the remaining
mutations. Alternatively, we cannot rule out additional
genetic heterogeneity in XLRP—that is, the possibility
that mutations in another gene, located in the proximity
of RPGR at Xp21.1, also cause retinitis pigmentosa.
Similar arguments have been advanced for other dis-
eases—for example, X-linked ocular albinism and X-
linked Alport syndrome—in which only one-third to
one-half of the patients reveal mutations in theOA1 and
COL4A5 collagen genes, respectively (Schiaffino et al.
1995; Knebelmann et al. 1996).
Different clinical presentations have been recognized
in XLRP (Fishman et al. 1988). The reported studies
will be beneficial in establishing correlation of RPGR
mutations with phenotypic variations observed in hem-
izygous males and heterozygous carrier females in XLRP
families. Because of their functional relevance,mutations
in the RCC1-homology repeats are predicted to result
in a relatively severe phenotype. Early attempts toward
genotype-phenotype correlation have been initiated (An-
dre´asson et al. 1997; Jacobson et al. 1997; Fishman et
al., in press) Nonetheless, further investigations are re-
quired for an understanding of the mechanism of disease
pathogenesis due to RPGR mutations.
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